Does PALBOCICLIB Cause Atelectasis? 44 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Atelectasis have been filed in association with PALBOCICLIB (Ibrance). This represents 0.1% of all adverse event reports for PALBOCICLIB.
44
Reports of Atelectasis with PALBOCICLIB
0.1%
of all PALBOCICLIB reports
4
Deaths
16
Hospitalizations
How Dangerous Is Atelectasis From PALBOCICLIB?
Of the 44 reports, 4 (9.1%) resulted in death, 16 (36.4%) required hospitalization, and 1 (2.3%) were considered life-threatening.
Is Atelectasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 44 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Atelectasis?
PREDNISONE (446)
ALBUTEROL (317)
METHOTREXATE (307)
CYCLOPHOSPHAMIDE (268)
DOXORUBICIN (215)
ADALIMUMAB (214)
ONDANSETRON (202)
RITUXIMAB (197)
DEXAMETHASONE (196)
PACLITAXEL (189)
Which PALBOCICLIB Alternatives Have Lower Atelectasis Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID